Latest filing published 20 Jun 2024 for Pacific Biosciences of California, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by William W. Ericson span 2 companies, the busiest being Pacific Biosciences of California, Inc. and Adamas Pharmaceuticals Inc. We count 6 filings; the first trade dates from 12 February 2021 and the latest from 18 June 2024.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 20 June 2024, the filings show a share grant in Pacific Biosciences of California, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations